Loading

Legalization

  • by Paul Armentano, NORML Deputy Director July 20, 2017

    Marijuana ScienceRevenues from Colorado’s legal cannabis industry have surpassed over a half-billion dollars since retail sales began on January 1, 2014.

    According to an analysis by VS Strategies, cannabis-related taxes and fees have yielded $506,143,635 in new state revenue over the past three and one-half years. (Local tax revenue was excluded from the analysis.) Much of the revenue raised has gone to fund school construction projects, school-drop out and substance abuse prevention programs, and grant funding.

    The half-billion dollar total far exceeds initial projections. Tax revenue from legal cannabis sales in Oregon and Washington have also exceeded regulators’ initial expectations. In Nevada, where retail sales to adult became legal on July 1, retailers reported over 40,000 transactions in just the first weekend.

  • by NORML July 18, 2017

    majority_supportOver the first six months of 2017, the American Automobile Association (aka AAA) has been spreading misinformation and propaganda in a lobbying effort to defeat marijuana legalization legislative efforts in Connecticut, Delaware, Maryland, and other states.

    As reported by Leafly.com, AAA representatives have recently preyed upon unsubstantiated fears regarding the alleged “increased plague of drugged driving” and the claim that “more babies will be born high” on marijuana in their lobbying efforts against adult use regulatory reforms. The distortions do nothing to advance the public debate surrounding legalization, but they do tarnish the organization’s reputation.

    Send a message to AAA telling them to put the brakes on lobbying against legalization efforts

    According to federal data, auto accident fatalities have fallen significantly over the past two decades – during the same time that a majority of US states have legalized marijuana for either medical or social use. In 1996 when California became the first state to legalize medical marijuana, the US National Highway Traffic Safety Administration reported that there were an estimated 37,500 fatal car crashes on US roadways. This total fell to under 30,000 by 2014.

    Further, a recently published study in the American Journal of Public Health reports that fatal traffic accident rates in legal marijuana states are no different than those in states where cannabis remains illegal. A separate study published last year in the same journal previously reported that the enactment of medical marijuana legalization laws is associated with a reduction in traffic fatalities compared to other states, particularly among younger drivers.

    One would hope that AAA would be nonpartisan in this debate; that they would be the group to separate the facts from the myths so that politicians and law enforcement would be more likely to pursue evidence-based policies with regard to regulating marijuana in a manner that strengthens public safety. Instead they’re largely fear-mongering and further politicizing the issue — calling for the continued criminalization and arrest of millions of Americans who choose to use marijuana privately and responsibly. By doing so, they are arguing in favor of the failed criminal justice policies of the past and they are alienating the 60 percent of Americans who endorse the outright legalization of recreational cannabis by adults (Gallup, 2016).

    Tell AAA to stop distorting the truth, send their public affairs department a message right now

    There are areas of public policy where AAA is absolutely in agreement with reform advocates, including NORML. For instance, we both agree that driving under the influence of cannabis should be discouraged and legally prohibited, and that the detection of either THC or its metabolites in blood or urine is not indicative of psychomotor impairment and, therefore, should not be used a legal standard of criminal liability.

    Our hope is that some day groups like NORML and AAA can work together to advocate for rational policies that work to keep our roadways safe from the threat of impaired drivers. Specifically, we recognize — as does AAA — that there is a need for greater tools and methods  to more accurately determine whether or not someone is under the influence of cannabis, such as via the use and promotion of handheld performance technology.

    Tell AAA that the days of ‘reefer madness’ are over. It’s time for a rational and evidence-based discussion regarding how best to regulate the use of marijuana by adults and how to keep our roads safe.

  • by NORML July 10, 2017

    take_actionNORML’s 2017 Conference at the Capitol Hilton in Washington, DC and Congressional Lobby Day at the United States Capitol is scheduled for September 10th-12th. Hundreds of marijuana consumers, activists, patients and business owners are expected to attend a day-long training and informational conference on Monday and re-convene on The Hill Tuesday to personally lobby their elected members of the House of Representatives and Senate.

    Whether you’re a longtime activist, college student, medical marijuana patient, or simply a NORML supporter, consider taking this all important step to directly lobby your members of Congress in support of common sense marijuana law reform. During your stay, you will meet and network with like minded activists from across the country, and your time on Capitol Hill will ensure that our message is brought face-to-face to those in Congress who need to hear it the most.

    Click here to sign up now

    We will be lobbying for expanded protections for those states that have reformed their laws, and to protect the progress that we have made from Attorney General Jeff Sessions and his rogue Justice Department. Time and time again, AG Sessions has made it clear that he thinks those of us who consume cannabis are “not good people.” We will be in the halls of Congress to set the record straight.

    The DMV NORML Social, benefiting DC, Virginia, and Maryland Chapters of NORML, will be held on Sunday, September 10, at The Dew Drop Inn, located at 2801 8th St NE, Washington, DC 20017 — a five minute walk from the Brookland-CUA Redline Metro Stop.

    The Conference portion of the event will be held Monday, September 11th at the Capitol Hilton which is located at 1001 16th St NW. It is walking distance from the Farragut West, Farragut North, and McPherson Square Metro Stations, and the Hilton is easily accessible from the Red, Blue, Orange, or Silver Metro Lines.

    The NORML Monday Night Party location details will be given to registered attendees in the weeks leading up to the event.

    Get your tickets now!

    See you in September,
    The NORML Team

  • by NORML June 30, 2017

    Nevada Legalized MarijuanaStarting on Saturday, July 1, specially licensed medical cannabis dispensaries in Nevada will have the opportunity to engage in the retail sale of marijuana to adults.

    State tax regulators finalized temporary rules on Monday governing adult use sales. Regulators so far have issued over 80 licenses to business establishments seeking to engage in activities specific to the production, testing, or sale of cannabis to adults.

    “Adults in Nevada will now be able to access cannabis in a safe, above ground, regulated environment,” NORML Political Director Justin Strekal said. “To their immense credit, lawmakers expeditiously to implement the will of their voters. Elected officials elsewhere would do well to follow Nevada’s example.”

    Adult use sales are anticipated to be limited because of an ongoing legal dispute regarding who may legally transport cannabis to retail stores. Last week, a Carson City judge issued an injunction prohibiting any entity other than liquor distributors from engaging in retail marijuana transport. As a result, retailers will only be able to sell their existing inventory.

    “While we applaud Nevada for moving to enact their voter approved legalization initiative in a timely fashion, interested parties must now move quickly and decisively to resolve the pending issues around distribution. If supply remains constrained in the state it will drive up prices and ultimately lead to most retail outlets being entirely out of sellable product for the recreational market.” NORML Executive Director Erik Altieri said. “This will only serve to continue to drive consumers to the black market, the very thing residents voted to demolish, and will deprive the state of needed tax revenue that will instead go to underground operators.”

    A majority of voters decided in November in favor of the Regulation and Taxation of Marijuana Act – a voter-initiated regulating the adult use marijuana market. In May, state regulated decided in favor of expediting the timeline for retail marijuana sales from January 1, 2018 to July 1, 2017.

    Seven additional states — Alaska, California, Colorado, Maine, Massachusetts, Oregon, and Washington — no longer impose criminal penalties with regard to the adult possession or use of cannabis.

    Businesses in the state still do not have protections from the Justice Department, led by militant prohibitionist Attorney General Jeff Sessions, who recently stated marijuana is “only slightly less awful” than heroin.

    You can click here to easily send a message to your federal lawmakers in support of pending legislation, HR 1227: The Ending Federal Marijuana Prohibition Act by clicking HERE.

  • by Paul Armentano, NORML Deputy Director June 28, 2017

    medical_mj_shelfPain patients report successfully substituting cannabis for opioids and other analgesics, according to data published online in the journal Cannabis and Cannabinoid Research.

    Researchers from the University of California, Berkeley and Kent State University in Ohio assessed survey data from a cohort of 2,897 self-identified medical cannabis patients.

    Among those who acknowledged having used opioid-based pain medication within the past six months, 97 percent agreed that they were able to decrease their opiate intake with cannabis. Moreover, 92 percent of respondents said that cannabis possessed fewer adverse side-effects than opioids. Eighty percent of respondents said that the use of medical cannabis alone provided greater symptom management than did their use of opioids.

    Among those respondents who acknowledged having recently taken nonopioid-based pain medications, 96 percent said that having access to cannabis reduced their conventional drug intake. Ninety-two percent of these respondents opined that medical cannabis was more effective at treating their condition than traditional analgesics.

    Authors concluded: “[M]ore people are looking at cannabis as a viable treatment for everyday ailments such as muscle soreness and inflammation. … [T]his study can conclude that medical cannabis patients report successfully using cannabis along with or as a substitute for opioid-based pain medication.”

    The study’s conclusions are similar to those of several others, such as these herehereherehere, and here, finding reduced prescription drug use and spending by those with access to cannabis. Separate studies report an association between cannabis access and lower rates of opioid-related abuse, hospitalizations, traffic fatalities, and overdose deaths.

    Full text of the study, “Cannabis as substitute for opioid-based pain medication: patient self-report,” appears online here.

Page 1 of 5012345...102030...Last »